EP 3442591 A1 20190220 - COMBINATIONS OF CD33 ANTIBODY DRUG CONJUGATES WITH HYPOMETHYLATING AGENTS
Title (en)
COMBINATIONS OF CD33 ANTIBODY DRUG CONJUGATES WITH HYPOMETHYLATING AGENTS
Title (de)
KOMBINATIONEN VON CD33-ANTIKÖRPER-WIRKSTOFF-KONJUGATEN MIT HYPOMETHYLIERUNGSMITTELN
Title (fr)
CONJUGUÉS PHARMACOLOGIQUES À BASE D'ANTICORPS ANTI-CD33 ASSOCIÉS À DES AGENTS HYPOMÉTHYLANTS
Publication
Application
Priority
- US 201662323206 P 20160415
- US 201662438376 P 20161222
- US 2017027246 W 20170412
Abstract (en)
[origin: WO2017180768A1] This invention relates to treatment of cancer using a CD33 antibody drug conjugate in combination with hypomethylating agents.
IPC 8 full level
A61K 47/50 (2017.01); C07K 16/28 (2006.01)
CPC (source: EP US)
A61K 31/5517 (2013.01 - US); A61K 31/706 (2013.01 - US); A61K 39/39558 (2013.01 - EP US); A61K 47/68035 (2023.08 - EP US); A61K 47/6849 (2017.08 - EP US); A61P 35/02 (2018.01 - EP US); C07K 16/2803 (2013.01 - EP US); A61K 2039/545 (2013.01 - EP US); C07K 2317/24 (2013.01 - US)
C-Set (source: EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017180768 A1 20171019; EP 3442591 A1 20190220; EP 3442591 A4 20191120; US 2019117787 A1 20190425
DOCDB simple family (application)
US 2017027246 W 20170412; EP 17783071 A 20170412; US 201716093947 A 20170412